|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Merck & Co., Inc. (MRK) Moves Global HQs to Cut Expenses, Consolidate Properties
10/9/2012 7:47:06 AM
In the latest big shift at Merck, the drugmaker is moving its global headquarters from one location in New Jersey to another. After being located in Whitehouse Station for 20 years in a complex that some derisively likened to CIA headquarters in Langley, Virginia, Merck is moving its key offices about 26 miles east to Summit, New Jersey, where it inherited facilities after acquiring Schering-Plough three years ago. The move, of course, is part of an ongoing cost-cutting program that also involves eliminating thousands of jobs and various facilities, including eight research sites and eight manufacturing plants. Last year, the drugmaker announced plans to shed 12,000 to 13,000 jobs by the end of 2015, which amounts to 12 percent to 13 percent of the 100,000 headcount as of the end of 2009. “The relocation of our headquarters will help us achieve our future vision, reduce the size of our operating footprint, and increase agility as we adapt to our changing business environment,” Merck ceo Ken Frazier says in a statement. About 2,000 employees and contractors currently at Whitehouse Station will move to Summit or to other nearby facilities in New Jersey, such as Branchburg and Cokesbury.
|
|
|
|
|
|
|
|
|
|
|